"Concerned by recently discovered dangers of relatively new arthritis and depression drugs, most Americans would prefer a drug that has been on the market at least a decade, according to a new survey.
'Seven out of 10 American consumers would prefer a drug that had been on the market for 10 years or more over newer drugs, even if the co-pays were equal,' according to the survey of 1,092 insured adults sponsored by pharmacy benefit manager Medco Health Solutions." [MaconDaily.com]
